Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,742.00    12.00 (0.32%)
Bid:
3,736.00
Ask:
3,750.00
Spread: 14.00 (0.375%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Directorate Change

12 Mar 2025 07:00

RNS Number : 2588A
4imprint Group PLC
12 March 2025
 

12 March 2025

4imprint Group plc

CFO Appointment

 

4imprint Group plc ("4imprint" or the "Company") today announces that Michelle Brukwicki will be appointed as CFO and a member of the Board with effect from 1 May 2025. On the same date, David Seekings will step down as CFO and from the Board, but will remain available to Michelle and the business until 30 June 2025 to ensure a continued smooth transition.

Paul Moody, Chair, commented: Alongside Kevin, David's contribution has been central to the phenomenal success that 4imprint has enjoyed over many years. His personal values and high integrity are evident in all that he has done and his positive commitment to all stakeholders has been unwavering. The Board sends its thanks and wishes him great success and happiness in the future.

Kevin Lyons-Tarr, CEO, commented: David's deep commitment to always doing the right thing for the business and its stakeholders has absolutely been an integral part of our success. From his first day with the Group through to his work to ensure a successful and effective succession, he has always given his very best. Working alongside him for more than two decades has truly been one of the highlights of my career. On behalf of everyone who has been part of the 4imprint journey I offer sincere thanks and best wishes to David and his family as he embarks on this next chapter. 

David Seekings, CFO, commented: During my 28 year career with the Company I have had the privilege of being part of a truly unique business at 4imprint. Over the years I have enjoyed working with many inspiring colleagues, including fellow Board members, Kevin and the leadership group, and all of the talented team members throughout the business who make 4imprint such an exceptional place to work. Whilst looking forward to a full and active retirement, I will miss my daily interactions with the 4imprint team, many of whom I can call my friends.

 

Notes: 

1. There is no further information in respect of Michelle Brukwicki which would require disclosure under Listing Rule 6.4.6.

2. Details of Michelle's remuneration arrangements were set out in the Company's announcement of 18 October 2024.

3. The information required to be disclosed under section 430(2B) of the Companies Act 2006 in relation to David Seekings will be available on the Company's website in due course. Consistent with his contractual terms and the Remuneration Policy, David will be paid salary, pension and benefits in the normal way until 30 June 2025. As a good leaver David will earn a pro rata FY25 bonus in relation to the period to 30 June 2025, and he will retain his outstanding deferred bonus awards, all subject to the relevant conditions. David will be bound by the post-cessation shareholding requirements in the Company's Remuneration Policy, requiring him to retain 4imprint shares to the value of 200% of base salary for a minimum of two years following his departure from the business. 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

Email: hq@4imprint.co.uk

MHP Group

Tel. + 44 (0) 7884 494112

Email: 4imprint@mhpgroup.com

 

 

Kevin Lyons-Tarr

Chief Executive Officer

 

Emma Taylor

Company Secretary

Katie Hunt

 

 

Eleni Menikou

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRGDXGDBDGUB
Date   Source Headline
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSHalf-year Report
17th Jun 202411:51 amRNSHolding(s) in Company
29th May 20249:27 amRNSEBT Purchase
22nd May 20243:25 pmRNSResult of AGM
22nd May 20247:00 amRNSCFO Succession
22nd May 20247:00 amRNSAGM Statement
16th May 20249:25 amRNSHolding(s) in Company
2nd May 20249:19 amRNSHolding(s) in Company
16th Apr 202410:23 amRNSAnnual Financial Report
3rd Apr 20243:42 pmRNSDirector/PDMR Shareholding
28th Mar 20241:58 pmRNSDirector/PDMR Shareholding
28th Mar 20249:05 amRNSEBT Purchase
13th Mar 20247:00 amRNSFinal Results
28th Feb 20248:33 amRNSHolding(s) in Company
13th Feb 20244:49 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTrading Statement
8th Jan 20248:27 amRNSBlock listing Interim Review
13th Dec 20238:52 amRNSCommittee changes
4th Dec 20231:23 pmRNSHolding(s) in Company
14th Nov 202312:28 pmRNSEBT Purchase
7th Nov 20237:00 amRNSTrading Statement
9th Oct 20238:17 amRNSEBT Purchase
21st Sep 20238:15 amRNSHolding(s) in Company
18th Aug 20238:09 amRNSDirectorate Change
1st Aug 20238:47 amRNSTrading Statement
31st Jul 20239:20 amRNSTotal Voting Rights
26th Jul 20233:23 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSPension Buy-in Transaction
29th Jun 20239:06 amRNSAdditional Listing
27th Jun 20239:41 amRNSBlock listing Interim Review
6th Jun 20231:36 pmRNSEBT Purchase
24th May 20232:12 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
12th May 20234:01 pmRNSHolding(s) in Company
17th Apr 20235:30 pmRNSAnnual Financial Report
14th Apr 20232:53 pmRNSHolding(s) in Company
29th Mar 20238:38 amRNSDirector/PDMR Shareholding
28th Mar 20238:04 amRNSEBT Purchase
15th Mar 20237:00 amRNSFinal Results
20th Jan 20237:00 amRNSTrading Statement
7th Dec 20223:38 pmRNSEBT Purchase
4th Nov 20227:00 amRNSTrading Statement
27th Oct 202212:42 pmRNSDirector Declaration
10th Oct 20229:01 amRNSEBT Purchase
16th Sep 20221:49 pmRNSHolding(s) in Company
12th Sep 20229:21 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.